Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Acyl-coenzyme A thioesterase 8 (ACOT8) is a peroxisomal enzyme that catalyzes the hydrolysis of acyl-CoA esters to free fatty acids and coenzyme A, thus regulating intracellular acyl-CoA and free fatty acid levels. It plays a significant role in fatty acid metabolism, including the β-oxidation pathway, and participates in the metabolism of bile acid CoA esters and dicarboxylic acids. ACOT8 displays broad substrate specificity for medium- to long-chain acyl-CoAs but is inactive on substrates with very long aliphatic chains. The enzyme is involved in metabolic regulation of peroxisome proliferation and interacts with the HIV-1 Nef protein, where it may mediate Nef-induced down-regulation of CD4 in T-cells, suggesting a possible link to HIV infection biology. Despite its central metabolic roles, no drugs directly target ACOT8 currently, and its function in human disease outside of rare associations remains under investigation.
Not applicable (no drugs established to act directly on ACOT8). Any future mechanism would likely involve inhibition or modulation of acyl-CoA hydrolysis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acyl-coenzyme A thioesterase 8 (ACOT8).